How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Flint coding model by Recursive offers up to 130 tokens per second on an M4 Mac. The new open-source AI leverages a mixture ...

FAC is trading near the bottom of its 52-week range and below its 200-day simple moving average. Price change The price of FAC shares has decreased $0.01 since the market last closed. This is a 0.23% ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Recent insider activity at Recursion Pharmaceuticals included 2 transactions totaling $97,222.74. One was a tax payment of $18,400.36 and the other was a sale of $78,822.38. Average transaction ...

View the basic RXRX option chain and compare options of Recursion Pharmaceuticals, Inc. on Yahoo Finance.